Annabell Szymansky

10PUBLICATIONS
66CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersCellular nervous systemCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 13, 2026
YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma Cells.

Marius Ludwig, Kerstin Ahrens, Annika Winkler

|Jan 06, 2025
Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with Neuroblastoma.

Jan F Hollander, Annabell Szymansky, Jasmin Wünschel

|Oct 26, 2024
Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis.

Annika Sprüssel, Takayoshi Suzuki, Naoki Miyata

|Oct 16, 2024
Management of Busulfan-Induced Lung Injury in Pediatric Patients with High-Risk Neuroblastoma.

Sveva Castelli, Anne Thorwarth, Claudia van Schewick

|Aug 07, 2024
Reconstructing extrachromosomal DNA structural heterogeneity from long-read sequencing data using Decoil.

Mădălina Giurgiu, Nadine Wittstruck, Elias Rodriguez-Fos

|Jul 04, 2023
Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN.

Steffen Fuchs, Clara Danßmann, Filippos Klironomos

Pageof 2